JOSEPH A MCCLURE MD NPI 1518948801

NPI Details

Joseph A Mcclure, MD is a medical oncology internal medicine in Melbourne, FL with 49 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Joseph A Mcclure, MD NPI is 1518948801. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1977

The provider's business location address is:

1130 HICKORY ST
SUITE B
MELBOURNE, FL
ZIP 32901
Phone: (321) 725-5600
Fax: (321) 724-4324

The NPI 1518948801 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Collection of blood sample from implanted device (HCPCS:36591)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Red blood cells, leukocytes reduced, each unit (HCPCS:P9016)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Transfusion of blood or blood products (HCPCS:36430)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 11/14/2005 and was last updated on 10/26/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.